ARS Pharmaceuticals cuts 2026 expenses after no new neffy coverage gains

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. DELL
4. MDB
5. GOOGL
6. VRTS
7. SPY
8. HPE
9. USO
10. SNOW

Go back to ARS Pharmaceuticals cuts 2026 expenses after no new neffy coverage gains
(NASDAQ: SPRY) Delayed: 5.82 +0.05 (0.87%)
Previous Close $5.77    52 Week High $ 
Open $5.86    52 Week Low $ 
Day High $6.00    P/E N/A 
Day Low $5.75    EPS $ 
Volume 1,196,979